##
|Trustees||Dr LRAdams|
|---|---|---|
|||Dr C Boyle|
|||Dr M KDeol|
|||Dr K Downie|
|||Dr C G P Holden|
|||Dr PC Howlett|
|||DrS Hughes|
|||DrSG Jones|
|||DrYLoo|
|||Dr D P Pearson|
|||DrSShah|
|||Dr Z Shehabi|
|||Mrs E KLee|
|||Dr M Majithia|
|Secrehsry||Dr M K Deol|
|Treasurer||Dr K Downie|
|Charity number||1107420|
|Company
number||05314579|
|Principal address||21 Portland Place|
|||London|
|||W1B1PY|
|Registered|office|21 Portland Place|
|||London|
|||W1B1PY|
|Independent|examiner|Silver Levene LLP|
|||Chartered
Certwed Accountants|
|||37Warren Street|
|||London|
|||W1T6AD|
##
||||Page|
|---|---|---|---|
|Trustees' report|||1-2|
|Independent
examiner's||report||
|Statement offinancial|activities|||
|Balance sheet||||
|Statement ofcash flows||||
|Notes to the financial|statements||7-15|
##
##
##
##
##
##
##
##
||||Unrestricted|Restricted|Total|Total|
|---|---|---|---|---|---|---|
|||Notes|funds
K|funds|2020f|2019|
|Subscriptions|||53,517||53,517|54,853|
|Charitable
activities|||144,559|2,240|146,799|511,876|
|Investments|||20,180||20,180|25,431|
|Other income|||20||20|20|
|Total income|||218,276|2,240|220,516|592,180|
|Charitable
actMties|||193,025|31,716|224,741|428,422|
|||12|3,278||3,278|4,908|
|Total resources expended|||196,303|31,716|228,019|433,330|
|Net gains/(losses)
on investments||13|(84,521)||(84,521)|69,503|
|Net movement|in funds||(62,548)|(29,476)|(92,024)|228,353|
|Fund balances at 1 January 2020|||817,028|102,896|919,924|691,571|
|Fund balances|at 31December 2020||754,480|73,420|827,900|919,924|
##
##
##
##
|||||2020||2019||
|---|---|---|---|---|---|---|---|
||||Notes|E||R||
|Gash flows from operating||activities||||||
|Cash (absorbed
by)/generated
operations||from|20||(28,276)||119,886|
|Investing activities||||||||
|Purchase oftangible fixed|assets|||||(4,503)||
|Interest received||||20,180||25,431||
|Net cash generated
from
activities|investing||||20,180||20,928|
|Net cash used in financing||activities||||||
|Net (decrease)/increase
equivalents|In|cash and|cash||(8,096)||140,814|
|Cash and cash equivalents|at beginning||ofyear||504,322||363,508|
|Gash and cash equivalents||at end of|year||496,227||504,322|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
||||Unrestricted|Unrestricted|
|---|---|---|---|---|
||||funds|funds|
||||2020|2019|
||Membership
fees||53,517|54,853|
|4|Charitable|Income|||
||||2020|2010|
||||f|f|
||Courses and conferences||142,929|393,408|
||Leaflets and publications||1,630|22|
||IHS loan scheme|||9,000|
||Evaluation|fee|2,240|109,446|
||||146,799|511,876|
||Analysis|by fund|||
||Unresbicted
funds||144,559|402,430|
||Restricted|funds|2,240|109,446|
||||146,799|511,876|
##
##
##
|||Unrestricted|Unrestricted|
|---|---|---|---|
|||funds|funds|
|||2020|2019|
|||R||
|Income|from listed investments|19,739|24,429|
|Interest|receivable|441|1,002|
|||20,180|25,431|
##
|Other|income|||
|---|---|---|---|
|||Unrestricted|Unrestricted|
|||funds|funds|
|||2020|2019|
|Other|income|20|20|
##
##
|Charitable
a|ctivities|||||
|---|---|---|---|---|---|
|||Resources|Governance|Total|Total|
|||Expended
f|Costs
f|2020f|2019f|
|Depreciation|and impairment|3,259||3,259|4,099|
|Courses and|conferences|60,001||60,001|221,563|
|Leaflets and|publications|25,400||25,400|23,799|
|Prizes||2,250||2,250|970|
|IHS loan scheme|||||4,728|
|Evaluation
expense||31,716||31,716|39,575|
|||122,626||122,626|294,734|
|Grant funding|ofactivities (see note 8)|27,991||27,991|3,530|
|Management|costs||71,444|71,444|127,278|
|Governance|costs||2,680|2,680|2,880|
|||150,617|74,124|224,741|428,422|
|Analysis
by|fund|||||
|Unrestricted|funds|118,901|74,124|193,025||
|Restricted funds||31,716||31,716||
|||150,617|74,124|224,741||
|For the year|ended 31December 2019|||||
|Unrestricted|funds|258,689|130,158||388,847|
|Restricted funds||39,575|||39,575|
|||298,264|130,158||428,422|
##
##
##
|Support costs|||||||
|---|---|---|---|---|---|---|
||Support|Governance|2020|Support|Governance|2019|
||costs|costs||costs|costs||
||R||R||||
|Management
and
administration|71,444||71,444|127,278||127,278|
|Accountancy||2,680|2,680||2,880|2,880|
||71,444|2,680|74,124|127,278|2,880|130,158|
|Analysed
between|||||||
|Charitable
activities|71,444|2,680|74,124|127,278|2,880|130,158|
##
##
||The avera|ge
monthly
number ofemployees
during|the year was:||
|---|---|---|---|---|
||||2020|2019|
||||Number|Number|
||Total||||
|12|Other||||
||||2020|2019|
||Financing|costs|3,278|4,908|
##
|Net gains/(l|osses)
on investments|||
|---|---|---|---|
|||Unrestricted|Unrestricted|
|||funds|funds|
|||2020|2019|
|||R||
|Revaluation|ofinvestments|(84,521)|69,503|
##
##
|Tangible fixed assets|||
|---|---|---|
|||Fixtures, flNnga a equipment|
|||R|
|Cost|||
|At 1 January 2020||68,271|
|At 31December 2020||68,271|
|Oepreciatlon
and impairment|||
|At 1 January 2020||46,543|
|Depreciation
charged|in the year|3,259|
|At 31 December 2020||49,802|
|Carrying
amount
At 31December 2020||18,469|
|At 31 December 2019||21,729|
|Fixed asset inves|tments||||
|---|---|---|---|---|
|||||Other|
|||||investments|
|Cost orvaluation|||||
|At 31 December 2020||||490,507|
|Valuation
changes||||(84,521)|
|At 31December 2020||||405,986|
|Carrying
amount|||||
|At 31December 2020||||405,986|
|At 31 December 2019||||490,507|
||||2020|2019|
|Other investments|comprise:|Notes|R||
|M &G Investments|||405,986|490,507|
##
##
##
|16|Debtors||||||||
|---|---|---|---|---|---|---|---|---|
||||||||2020|2019|
||Amounts
falling due|within|one year.||||R||
||Prepayments
and accrued income||||||875||
|17|Creditors: amounts|falling due within||one year|||||
||||||||2020|2019|
||||||||R||
||Acciuals and deferred|income|||||6,922||
|18|Analysis ofnet assets between funds||||||||
|||Unrestricted||Restricted|Total|Unrestricted|Restricted|Total|
||||funds|funds||funds|funds||
||||2020|2020|2020|2019|2019|2019|
||||R||R|||E|
||Fund balances at 31||||||||
||December 2020are||||||||
||represented
by:||||||||
||Tangible assets||18,469||18,469|21,729||21,729|
||investments||405,986||405,986|490,507||490,507|
||Current assets/||||||||
||(liabilities)||416,760|73,420|490,180|401,426|102,896|504,322|
||Provisions
and||||||||
||defened income||(86,735)||(86,735)|(96,634)||(96,634)|
||||754,480|73,420|827,900|817,028|102,896|919,924|
##
|There were no disdosabie
related party transactions
during the year (201|There were no disdosabie
related party transactions
during the year (201|9 - none).||
|---|---|---|---|
|Cash generated
from operations|||2019|
|(Deficit)/surpus
for the year||(92,024)|228,353|
|Adjustments
for:||||
|investment
income recognised|in statement offinancial activities|(20,180)|(25,431)|
|Fair value gains and losses on investments
Depreciation
and impairment
oftangible fixed assets||84,521
3,259|(69,503)
4,099|
|Movements
in working
capital:||||
|(Increase) in debtors||(875)||
|Increase
in creditors||6,922||
|(Decrease) in deferred income||(9,899)|(17,632)|
|Gash (absorbed by)/generated|from operations|(28,276)|119,886|
##